Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × mirdametinib × Clear all

NCT05580770 2026-05-01

Mirdametinib + BGB-3245 in Advanced Solid Tumors

Phase 1/2 Terminated

23 enrolled 22 charts

Other solid neoplasm

Advanced Solid Tumor